A	B	C	D	E	F	G	H	I	J	K	L	M	N	O	P	Q	R	S	T	U	V	W	X	Y	Z	AA	AB	AC	AD	AE	AF	AG
1	Main
2									1/29/2021	4/30/2021	7/29/2021	10/30/2021	1/28/2022	4/29/2022	7/29/2022	10/30/2022	1/27/2023	4/29/2023				4/26/2019	4/24/2020	4/29/2021	4/29/2022	4/29/2023	4/29/2024	4/29/2025	4/29/2026	4/29/2027	4/29/2028	4/29/2029	4/29/2030
3			FQ120	FQ220	FQ320	FQ420	FQ121	FQ221	FQ321	FQ421	FQ122	FQ222	FQ322	FQ422	FQ123	FQ223	FQ323	FQ423			FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	FY27	FY28	FY29	FY30
4		Cranial/Spinal							1081	1192	1123	1067	1102	1165	1043	1081	1128
5		Specialty Therapies							618	654	641	634	633	684	667	686	699
6		Neuromodulation							426	449	440	435	409	451	405	419	420
7
8		Diabetes							630	647	572	585	584	597	541	556	570
9
10		Respiratory							890	796	768	802	771	740	664	671	712
11		Surgical Innovations							1423	1542	1554	1497	1519	1491	1338	1398	1425
12
13		Coronary/Peripheral							605	624	620	606	603	631	579	584	581
14		Structural Heart							730	744	787	750	740	778	741	757	760
15		Cardiac Rhythm							1371	1539	1483	1471	1402	1552	1393	1431	1431
16		Revenue							7774	8187	7988	7847	7763	8089	7371	7583	7727					30557	28913	30117	31686
17		COGS							2621	2652	2491	2497	2459	2544	2467	2535	2689					9155	9424	10483	10145
18		Gross Profit							5153	5535	5497	5350	5304	5545	4904	5048	5038					21402	19489	19634	21541
19		SG&A							2537	2594	2547	2615	2561	2569	2518	2617	2615					10418	10109	10148	10292
20		R&D							601	632	436	431	668	652	678	676	688					2330	2331	2493	2746
21		OpEx							3138	3226	2983	3046	3229	3221	3196	3293	3303					12748	12440	12641	13038
22		OpInc							2015	2309	2514	2304	2075	2324	1708	1755	1735					8654	7049	6993	8503
23		Interest Income							-139	-238	-26	-70	-7	-212	-116	-9	-18					-1329	-777	274	-627
24		Pretax Income							1876	2071	2488	2234	2068	2112	1592	1746	1717					7325	6272	7267	7876
25		Taxes							-68	206	64	176	110	116	112	0	146					547	768	289	478
26		Net Income							1944	1865	2424	2058	1958	1996	1480	1746	1571					6778	5504	6978	7398
27		EPS							1.4336283185840708	1.3729387514723204	1.7870834562076083	1.5184829926953443	1.4500481374509369	1.4841252137705405	1.1090295991007868	1.3108108108108107	1.1794294294294294					4.993001841620626	4.073717711494338	5.153618906942393	5.4743229243747225
28		S/O							1356	1358.4	1356.4	1355.3	1350.3	1344.9	1334.5	1332	1332					1357.5	1351.1	1354	1351.4
29
30
31
32
33		Revenue Growth											-0.0014149729868793148	-0.011970196653230736	-0.07724086129193786	-0.03364343061042441	-0.004637382455236372	-1					-0.05380109303923819	0.04164216788295927	0.05209682239266855
34		Gross Margin							0.6628505273990224	0.6760718211799194	0.6881572358537806	0.6817892188097362	0.6832410150714929	0.6854988255655828	0.665309998643332	0.6656995911908216	0.6519994823346706	#ERROR_#DIV/0!				0.7003959812808849	0.674056652716771	0.6519241624331773	0.679827052957142
35
36
37		CFFO																			4684	7007	7234	6240	7346
38		CapEx																			1068	1134	1213	1355	1368
39		CFFO																			3616	5873	6021	4885	5978